Important COVID-19 guidelines
Please ensure you have read our latest statement on COVID-19 and RCR examinations before applying for or attending an examination. Should any candidate feel unwell or display symptoms they should not attend the examination.
Examination format update
This examination will be proctored online. The examination is delivered by a software (Speedwell) which can now be integrated with Examity’s examination proctoring system, allowing candidates to take secure high stake examinations at home or at a place of the candidate’s choosing where they should have a stable internet connection, a quiet working atmosphere and must be on their own. See examination specification for further details.
February 2021 examination sitting update
In light of the current situation, we have taken the decision to postpone the FRCR Part 1 and Final Part A examinations in Clinical Oncology planned to be held in February. We believe that planning to go ahead in February would be impractical and would pose far too much risk when the NHS is close to breaking point, and the situation is unlikely to improve for some weeks. The NHS is in a more difficult position than when we cancelled our FRCR examinations last spring. Whilst we have adapted the examination delivery, we could not justify going ahead in the face of the national emergency we currently encounter. We know that many trainees are being redeployed or having their training and preparation disrupted in other ways.
The new examination date for the Final FRCR Part A examination in Clinical Oncology will be Thursday 29th April 2021.
The Final FRCR Part A examination in Clinical Oncology will now be after the Part B examination which runs from 17th to 22nd April 2021. Priority 1 candidates (UK trainees and all NHS contributors) who applied for the Final FRCR Part A examination in Clinical Oncology in February 2021, that wish to attempt both Part A and Part B will now take the Final FRCR Part B examination first and continue to the Final FRCR Part A examination regardless of the outcome. Priority 2 Final Part A candidates will automatically be moved to the new date in April shown above, but will not be entered for the Final FRCR Part B April examination.
A pass in the Final FRCR Part A examination will be valid for future attempts at the Final FRCR Part B examination, should they be needed. A candidate who passes the Final FRCR Part B examination but then fails the Final FRCR Part A examination would need to complete Part A examination at a future sitting for the award of FRCR and CCT, but would not need to repeat the Final FRCR Part B examination in Clinical Oncology.
We hope that this new timing will have minimal impact on trainee progression decisions as results will be available before most ARCPs take place. The curriculum derogations, adjusted decision aids and outcomes 10.1 and 10.2 as agreed last year will still apply at ARCPs.
All Part A bookings will be immediately transferred to the new examination date in April and no further action is required by candidates. Please contact firstname.lastname@example.org if you are not able to sit the April 2021 sitting and would like to be moved to the September 2021 sitting instead.
Dual applications for the Final FRCR Part A and Part B examinations in Clinical Oncology (April 2021 sitting)
Following what is stated on the guidance notes for the Final FRCR Part A examination, please note the Final FRCR Part B examination applications open on January 8; therefore, the RCR examinations team will manually book any Priority 1 candidates who have applied for the Final FRCR Part A onto the Final FRCR Part B at the same venue. This is a provisional booking with pending payment and candidates will receive an email by Friday 22 January. Please make payment through MyRCR upon receipt of this email.
Purpose of assessment
The Final FRCR (Part A) Examination expects candidates to have a wide knowledge of malignant disease and the management of patients with cancer. The main emphasis is on radiotherapy and drug therapy, but a good knowledge of general medicine, surgery and gynaecology is expected. Candidates are examined against the specialty training curriculum for clinical oncology and the clinical oncology syllabus. The Final FRCR (Part A) Examination comprises two papers of 120 single best answer (SBA) questions. Further general information on the examination is available in the guidance notes. Please note that for candidates who are eligible and wish to apply for the Final FRCR (Part B) examination at the same examination sitting of the Final FRCR (Part A) examination, they must apply within the corresponding application date. Once the results of the Final FRCR (Part A) examination are published, the sucssesful candidates will be asked to pay for the Final FRCR (Part B) examination accordingly.
The Final FRCR Examination purpose of assessment statement details the examination's purpose, the required level of candidate training and the application of results. It is hoped that the statement will assist candidates, and those involved in their training, in understanding the scope of the FRCR examination and with relating the examination to other in-training assessments.
Dates, fees & venues
How to apply
Applicants should ensure they have read the examination regulations before applying.
- Sample SBA questions and candidate reference sheet for use during the examination.
- Advice for candidates from trainees who have already sat the examination.
- Generic examiners' reports are available as a guide to candidates and trainers preparing for future sittings of the examination.
The Final Examining Board suggests that candidates prepare for the examination using TNM version 8. The examiners are, however, aware that previous versions remain in common use around the country and will generally use questions where trainees more familiar with TNM version 7 are still able to answer the questions successfully.